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Purpose: The purpose of this investigation was to estimate the population-based prevalence of renovascular disease (RVD),
defined as>60% diameter-reducing renal artery stenosis or occlusion, and to define its associations with age, gender, race,
and other potential risk factors among participants in the Cardiovascular Health Study (CHS).
Methods: The CHS is a multicenter, longitudinal cohort study of cardiovascular disease risk factors, morbidity, and
mortality among free-living adults of more than 65 years of age. As part of an ancillary investigation, participants in the
Forsyth County cohort of the CHS were invited to undergo renal duplex sonography (RDS) to define the presence or
absence of RVD. RVD was defined as stenosis with a focal renal artery peak systolic velocity exceeding 1.8 m/s in the main
renal artery and defined as occlusion when an imaged renal artery lacked a Doppler signal. Demographic and
atherosclerotic risk factor data were gathered as part of the baseline CHS examination. Univariable tests of association
were performed with 2 and Student t tests and logistic regression analysis. Multivariate associations were examined with
logistic regression analysis.
Results: Eight hundred seventy CHS participants underwent RDS. Of these examinations, 834 (96%) were technically
adequate to define the presence or absence of RVD. The RDS study cohort had a mean age of 77.2  4.9 years and
consisted of 63% women and 37% men. Participant race was 76% white and 23% African American. The overall prevalence
rate of RVD was 6.8%. Among the 57 patients with RVD, 50 (88%) had unilateral disease and seven (12%) had bilateral
disease. Seven cases were seen of renal artery occlusion, including one case with contralateral renal artery stenosis. The
mean ages of patients with and without RVD were 78.7  5.7 years and 77.1  4.9 years (P  .018). RVD was present
in 5.5% of women and 9.1% of men (P  .053). RVD was present in 6.9% of white participants and 6.7% of African
American participants (P  .933). Multivariate analysis revealed increasing participant age (P  .028; odds ratio, 1.34;
95% CI, 1.03, 1.73), high-density lipoprotein cholesterol levels of less than 40 mg/dL (P  .003; odds ratio, 2.63; 95%
CI, 1.40, 4.93), and increasing systolic blood pressure (P .007; odds ratio, 1.44; 95% CI, 1.10, 1.87) to be significantly
and independently associated with the presence of RVD.
Conclusion: This investigation provides the first population-based estimate of the prevalence of RVD among free-living,
elderly black and white Americans. RVD was present in 6.8% of the study cohort. RVD showed no association with
ethnicity. However, its presence was significantly and independently associated with increasing age, low high-density
lipoprotein cholesterol levels, and increasing systolic blood pressure. (J Vasc Surg 2002;36:443-51.)
By contributing to hypertension, hemodynamically sig-
nificant atherosclerotic renovascular disease (RVD) may
increase the risk of coronary heart disease and stroke in the
elderly.1,2 In addition, as a subclinical marker for general-
ized atherosclerosis, RVD may be associated with these
adverse cardiovascular outcomes.3-5 Moreover, RVD may
also decrease effective renal plasma flow to produce excre-
tory renal insufficiency.6-8 Unfortunately, the actual con-
tribution of RVD to these important health issues is uncer-
tain because the prevalence of RVD in the elderly is
unknown.
Existing estimates of RVD have not included study of
population-based samples. As a result, available data re-
garding the prevalence of RVD in the elderly are varied and
incomplete. Until recently, accurate detection of RVD has
required angiography. However, because of its inherent
risks, potential complications, and expense, the application
of angiography to a large population-based sample was
inappropriate.9 Consequently, prior estimates of RVD in
the elderly have been made from case series autopsy exam-
inations or angiography obtained to evaluate secondary
hypertension or other diseases of the peripheral circula-
tion.10-16 Although inferior to accurate noninvasive meth-
ods applied to a large population-based sample, these data
suggest that RVD is prevalent and that its prevalence in-
creases with age.
This study uses renal duplex sonography (RDS) to
detect the presence of RVD. This noninvasive ultrasound
scan technique was applied to the participants of the
Forsyth County, NC, cohort of the ongoing NHLBI-
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sponsored Cardiovascular Health Study (CHS). The CHS
is a longitudinal, prospective, population-based study of
coronary heart disease and stroke in elderly men and
women. The application of RDS to the CHS Forsyth
County cohort provided a unique opportunity to estimate
the prevalence of RVD in elderly, free-living, community-
dwelling black and white men and women. Specifically, the
primary areas of interest included: 1, the prevalence of
hemodynamically significant renal artery stenosis or occlu-
sion; and 2, the association of RVD with age, gender, race,
and atherosclerotic risk factors.
METHODS
Study subjects. The prevalence of RVD, defined as
60%diameter-reducing renal artery stenosis or occlusion,
was estimated in the Forsyth County, NC, cohort of the
CHS with RDS. The CHS is an observational, population-
based longitudinal study of risk factors for coronary heart
disease and stroke in adults of age 65 years and older.17 The
primary aim of the CHS is to identify and assess factors
related to the onset of coronary heart disease and stroke in
this age group. The CHS study design required each of four
field centers from four US communities (Forsyth County,
NC; Sacramento County, Calif; Washington County, Md;
and Allegheny County, Pa) to recruit and examine not less
than 1250 men and women during the first study year
beginning June 1989, for a total of at least 5000 subjects
study wide.
Each community sample was obtained with a two-step
process from Medicare eligibility lists of the Health Care
Financing Administration. These Health Care Financing
Administration lists were sampled from a random start to
produce sampling frames of approximately 5000 potential
participants in each community. Random samples were
selected from the sampling frames with a customized pro-
gram to produce a Forsyth County cohort with a 62:38
female/male ratio in each of four age strata, with the
following distribution within each baseline strata: 65 to 69
years, 30%; 70 to 74 years, 29%; 75 to 79 years, 19%; and
more than 80 years, 22%. Those eligible to participate
included all persons living in each sampled household who
were 65 years of age and older, were not institutionalized,
were expected to remain in the area for at least a 3-year
follow-up period, were able to give informed consent, and
did not require a proxy respondent at baseline. Individuals
who were undergoing hospice treatment, radiation ther-
apy, or chemotherapy for cancer or who were wheelchair
bound were excluded. The overall Forsyth County partici-
pation rate was 61%. Those initially sampled made up 70%
of the overall CHS cohort, with the remaining 30% re-
cruited from a shared household with the index partici-
pant.18 Between September 1992 and May 1993, 236
additional African American participants were recruited
into the Forsyth County cohort with the same sampling
and recruitment techniques. These techniques provided
the following Forsyth County CHS enrollment distribu-
tion within each age strata: 65 to 69 years, 32%; 70 to 74
years, 29%; 75 to 79, 22%; and more than 80 years, 17%.
Atherosclerotic risk factors were assessed during the
baseline CHS examination, which consisted of a home
interview and a clinical examination. These risk factors are
defined in Table I. The home interview included question-
naire assessment and information on all prescription medi-
cations taken in the prior 2 weeks.
Clinical examinations were scheduled in the morning at
the CHS Field Center after a 12-hour fast. Sitting blood
pressures and venipuncture were performed early in the
examination. With an appropriately sized cuff, blood pres-
Table I. Demographics and baseline atherosclerotic risk factors among CHS participants (n  1245)
Variable Definition Recruited (n  870) Nonrecruited (n  375) P value
Age* Age in years (mean, SD) 77.3  4.9 79.7  5.9 .001
Race .397
African-American 201 (23.1%) 95 (25.3%) –
White or other 669 (76.9%) 280 (74.7%) –
Gender .753
Female 544 (62.5%) 238 (63.5%) –
Male 326 (37.5%) 137 (36.5%) –
Systolic blood pressure mm Hg (mean, SD) 135  21 139  23 .001
Diastolic blood pressure mm Hg (mean, SD) 72  10 73  12 .209
Clinical hypertension Systolic blood pressure 160 mm Hg or
diastolic blood pressure 95 mm Hg
or antihypertensive medication use
360 (41.4%) 172 (46.1%) .126
Diabetes mellitus Fasting glucose 140 mg/dL or 2-hour
post glucose load 200 mg/dL or
insulin or oral hypoglycemic agent use
147 (20.5%) 74 (23.7%) .248
Cigarette smoking Ever/never 401 (46.4%) 208 (56.1%) .002
Hypercholesterolemia Total cholesterol 240 mg/dL 157 (18.3%) 69 (18.8%) .859
Elevated LDL-C LDL-C 130 mg/dL 140 (16.6%) 66 (18.1%) .502
Decreased HDL-C HDL-C 40 mg/dL 139 (16.2%) 56 (15.2%) .655
Obesity 130% ideal body weight 263 (30.2%) 90 (24.0%) .025
*Age at time of renal duplex sonography.
SD, Standard deviation; LDL-C, low-density lipoprotein cholesterol.
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sure was measured in the right arm of seated participants
after a 5-minute rest period, and the average of two mea-
surements was used to determine the systolic (ie, first
Korotkoff’s sound) and diastolic (ie, fifth Korotkoff’s
sound) blood pressures. Venipuncture was performed early
in the clinic visit. Aliquots of plasma were prepared, frozen
at 70° C, and shipped weekly on dry ice to the central
blood analysis laboratory. Fasting plasma lipid analyses
were performed on an Olympus Demand system (Olympus
Corporation, Lake Success, NY). Measurements included
total cholesterol, high-density lipoprotein cholesterol
(HDL-C), and triglycerides, standardized according to the
Centers for Disease Control. Low-density lipoprotein cho-
lesterol (LDL-C) was calculated according to Fried et al.17
Renal duplex sonography. As an ancillary study
funded through the National Institute of Diabetes and
Digestive and Kidney Disease, CHS participants in the
Forsyth County cohort were studied with RDS between
January 1995 and February 1997. Participants scheduled
for routine annual examination were contacted by tele-
phone and informed of this ancillary project. This study was
approved by the Wake Forest University Human Subjects
Review Committee.
RDS was performed with an Ultramark-9 HDI Ultra-
sound System (Advanced Technologies Laboratories,
Bothell, Wash). All RDS was performed by two registered
vascular technologists with extensive experience in renal
artery evaluation. Written informed consent was obtained
from CHS participants on return for their annual examina-
tion. During that same visit, consenting participants were
studied with RDS at the CHS Forsyth County Field Cen-
ter. As part of the annual examination, CHS participants
had fasted overnight.
The technique of RDS has been described previous-
ly.19,20 With the participant supine, a 2.25-mHz or 3.0-
mHz ultrasound probe was coupled to the abdominal skin
with acoustic gel 3 or 4 cm inferior to the xiphoid process.
A sagittal B-scan image was obtained of the upper abdom-
inal aorta, celiac axis, and superior mesenteric arteries.
Identification of these vessels was confirmed with the char-
acteristic fasting Doppler waveform from each vessel. After
a sagittal aortic and superior mesenteric artery signal was
obtained, the probe was rotated 90 degrees to obtain a
B-scan image of the aorta and proximal superior mesenteric
artery in cross section. The left renal vein was identified in
longitudinal section. With the left renal vein as a reference,
the aortic origins of both main renal arteries were identi-
fied. Doppler samples were taken from each renal artery
from aortic origin to the renal hilum, maintaining the angle
of insonation at less than 60 degrees. Approximately 10
Doppler sample sites were taken per renal artery. The angle
of insonation was estimated and combined with the spectral
analysis from the Doppler-shifted signal, and the renal
artery peak systolic velocity (PSV; m/s) was estimated.
After Doppler interrogation in the supine position, renal
artery PSV was confirmed with a flank approach with the
participant in right or left lateral decubitus position. In the
decubitus position, a B-scan image of each kidney was
obtained and kidney length determined.
All B-mode and Doppler spectral data were collected
on super VHS tape and transferred to an electronic data-
base. This process was repeated, and the data were com-
pared for agreement. A 3% discordance in electronic data
was adjudicated from review of the original duplex study.
A prior study showed that a 60% diameter-reducing
stenosis was necessary before a decrease in distal renal artery
perfusion pressure and blood flow was reliably observed.19
Hence, for the purposes of this report, RDS study was
considered negative or positive for hemodynamically signif-
icant RVD or inadequate for interpretation according to
the following criteria: 1, RDS was negative for RVD when
renal artery PSV from aortic origin to renal hilum was less
than 1.8 m/s; 2, RDS was positive for RVD when there was
a focal increase in renal artery PSV of 1.8 m/s or more
(60% renal artery diameter-reducing stenosis) or no
Doppler signal was obtained from an imaged artery (renal
artery occlusion); and 3, RDS was technically inadequate
for interpretation when renal artery PSV could not be
determined from the entire renal artery from aortic origin
to renal hilum. These RDS criteria for 60% diameter-
reducing renal artery stenosis have been validated prospec-
tively in comparison with conventional renal angiogra-
phy.19,20
Statistical analysis. After ancillary study data were
keyed and verified, RDS results were matched with partic-
ipant data provided by the CHS Coordinating Center. For
the original cohort, baseline data were measured 5 to 7
years before RDS examination. Among the enriched Afri-
can American cohort, baseline data were determined 2 to 4
years before RDS study. Differences among those who
consented to RDS examination compared with those who
declined RDS were assessed with 2 tests for dichotomous
factors and t tests for continuous factors. Similar methods
were applied to participants with technically satisfactory
and technically incomplete RDS examinations. Univariate
and multivariate analyses of associations between selected
variables and the presence of RVD were performed with
logistic regression models. Variables of interest included
those listed in Table I. A “best” logistic model was con-
structed with a forward stepwise variable selection where,
beginning with the most significant, individual variables
with a P value of less than .15 were selected one by one for
model inclusion. All variables remaining significant at a .10
 level were included in the final model.21
RESULTS
Between January 1995 and February 1997, 1245 For-
syth County participants returned to the CHS Field Center
for annual examination. Among returning participants, 870
gave consent for RDS, providing 69.9% recruitment effi-
ciency. Table I defines the atherosclerotic risk factors exam-
ined and compares the CHS participants recruited for RDS
with those who were not evaluated for RVD. Compared
with participants recruited, participants not evaluated for
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RVD were significantly older, had higher systolic blood
pressure at baseline, and had a greater rate of tobacco use.
The study cohort recruited for RDS examination con-
sisted of 544 women (63%) and 326 men (37%), with a
mean age of 77.3  4.9 years. The study group included
669 white (77%) and 201 African American (23%) CHS
participants. The average time for RDS examination was
18.3  3.9 minutes.
Of these 870 RDS examinations, 834 (96%) were tech-
nically satisfactory to define the presence or absence of
RVD. Table II compares demographic characteristics and
atherosclerotic risk factors between 834 participants with
technically satisfactory RDS with 36 participants with tech-
nically inadequate RDS for interpretation. Compared with
technically satisfactory examinations, participants with in-
adequate RDS were older at the time of RDS and had
significantly greater obesity and hypertension at baseline.
With consideration of all 870 participants, a significant
association was seen between obesity and hypertension:
51% of CHS participants obese at baseline had hyperten-
sion compared with 36% without obesity (P  .0001).
Overall, 57 of 834 participants (6.8%) successfully stud-
ied with RDS had RVD (Table III). RDS studies positive
for RVD included 50 patients (88%) with unilateral renal
artery disease and seven patients (12%) with bilateral dis-
ease. Of the 64 renal arteries with RVD, 57 kidneys had a
hemodynamically significant renal artery stenosis and seven
renal arteries were considered occluded.
Mean PSV associated with stenotic RVD was 2.64 
0.98 m/s compared with 1.06  0.28 m/s in the absence
of RVD. Pole-to-pole mean renal length for RDS studies
positive for RVD (10.3  1.6 cm) did not differ signifi-
cantly from renal lengths from kidneys negative for RVD
(10.5  1.0 cm; P  .307). However, among kidneys
positive for RVD, mean renal length differed significantly
for 60% renal artery diameter-reducing stenosis (10.6 
1.3 cm) compared with renal artery occlusion (7.9  1.3
cm; P  .001).
Table III summarizes RVD prevalence relative to the
age strata at the time of duplex examination. The distribu-
tion of RVD by strata was: 65 to 69 years, 4/29 (13.8%),
70 to 74 years, 10/300 (3.3%), 75 to 79 years, 20/277
(7.2%), and 80 years or more, 23/228 (10.1%).
Table IV summarizes the univariate analysis of associa-
tions between demographic features and atherosclerotic
risk factors and RVD. Increased participant age showed a
significant association with the presence of RVD. Partici-
pants with RVD averaged 78.7  5.7 years compared with
participants without RVD who averaged 77.1  4.9 years
(P  .018).
Participant gender suggested a univariate association
with the presence and absence of RVD (Tables III and IV).
Overall, 5.5% of female participants and 9.1% of male
participants had RDS studies positive for RVD (P .053).
Table III. Prevalence of RVD among recruited CHS
participants
Category (no. of participants) Prevalence of RVD
Overall (n  834) 6.8%
Age strata*
65 to 69 years (n  29) 13.8%
70 to 74 years (n  300) 3.3%
75 to 80 years (n  277) 7.2%
80 years (n  228) 10.1%
Gender
Female (n  525) 5.5%
Male (n  309) 9.1%
Race
African-American (n  194) 6.7%
White (n  635) 6.9%
Other (n  5) 0.0%
*Age at time of renal duplex sonography.
Table II. Summary statistics for CHS participants studied with renal duplex sonography (n  870)
Variable* Technically satisfactory (n  834) Technically incomplete (n  36) P value
Age (y; mean, SD)† 77.2  4.9 79.0  3.9 .040
Gender .217
Female 525 (63.0%) 19 (52.8%) –
Male 309 (37.0%) 17 (47.2%) –
Race .595
African-American 194 (23.3%) 7 (19.4%) –
White and other 640 (76.7%) 29 (80.6%) –
Systolic blood pressure (mm Hg; mean, SD) 135  21 140  20 .138
Diastolic blood pressure (mm Hg; mean, SD) 72  11 74  9 .458
Clinical hypertension 336 (40.3%) 24 (66.7%) .002
Diabetes mellitus 138 (20.2%) 9 (28.1%) .275
Smoking 383 (46.2%) 18 (50.0%) .655
Hypercholesterolemia 153 (18.6%) 4 (11.4%) .282
Elevated LDL-C 136 (16.8%) 4 (11.4%) .405
Decreased HDL-C 135 (16.4%) 4 (11.4%) .431
Obesity 245 (29.4%) 18 (50.0%) .008
*See Table I for variable definitions.
†Age at time of renal duplex sonography; all other variables assessed at baseline.
SD, Standard deviation; LDL-C, low-density lipoprotein cholesterol.
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The presence of hemodynamically significant renal artery
stenosis (8.1% men; 5.0% women; P  .068) and renal
artery occlusion (1.0% men; 0.8% women; P  .714) did
not differ by gender.
In contrast, participant race did not show an association
with the presence or absence of RVD (Tables III and IV).
Including African American participants recruited into the
original Forsyth County cohort, 6.9% of white participants
and 6.7% of African American participants had RVD (P 
.933). The extent (unilateral/bilateral) and severity (steno-
sis/occlusion) of RVD did not differ by race. However, an
insignificant trend was seen in the prevalence of RVD when
race was considered by gender. Among white participants,
4.9% of women and 10.4% of men had RVD. In contrast, in
African American participants, 7.3% of women and 5.3% of
men had RVD with RDS.
Among the atherosclerotic risk factors defined in Table
I, only decreased HDL-C and increased systolic blood
pressure showed statistically significant associations with
RVD (Table IV). Clinical hypertension showed a trend
toward association with RVD. When baseline blood pres-
sure was considered as a continuous variable, systolic but
not diastolic pressure was statistically higher among partic-
ipants with RVD. An 8–mm Hg difference in mean base-
line systolic blood pressure was observed between partici-
pants with and without RVD. These relationships between
clinical hypertension, systolic and diastolic blood pressure,
and the presence of RVD were not altered with participant
use of antihypertensive agents. Tobacco use, diabetes mel-
litus, obesity, and elevated low-density lipoprotein choles-
terol showed no apparent association with RVD when
considered as either categoric or continuous variables with
univariate analyses.
Table V summarizes the results of the multivariate
analysis after forward stepwise variable selection. In this
analysis, patient gender did not retain a significant associa-
tion with RVD. However, increasing patient age (by 5-year
increments) showed a significant and independent associa-
tion with RVD (odds ratio, 1.34; 95% CI, 1.03, 1.73; P 
.028). Among atherosclerotic risk factors, only decreased
HDL-C (odds ratio, 2.63; 95% CI, 1.40, 4.93; P  .003)
and increasing systolic blood pressure (odds ratio, 1.44;
95% CI, 1.10, 1.87; P  0.007) showed associations with
RVD that were significant and independent.
DISCUSSION
This study estimated the prevalence of RVD among
participants of the CHS with RDS. Overall, 6.8% of partic-
ipants had a60% renal artery stenosis or occlusion. When
present, RVD most commonly existed as unilateral renal
artery stenosis, with equal frequency among white and
black participants. Although univariate analysis suggested a
gender-related difference in RVD, only increasing age,
increasing systolic blood pressure, and decreased HDL-C
levels showed significant and independent associations with
the presence of RVD.
Similar relationships between age, HDL-C, and systolic
blood pressure with other estimates of subclinical athero-
sclerosis have been described for CHS participants. Kuller
Table IV. Results of univariate analysis for RVD and associated risk factors
Variable* Participants with RVD (n  57) Participants without RVD (n  777) Odds ratio 95% CI P value
Age† (y) 78.7  5.7 77.1  4.9 1.35 1.05, 1.73 .018
Gender 1.70 0.99, 2.92 .053
Female 29 (51%) 496 (64%) – – –
Male 28 (49%) 281 (36%) – – –
Race 0.97 0.51, 1.85 .933
African-American 13 (23%) 181 (23%) – – –
Caucasian and other 44 (77%) 596 (77%) – – –
Systolic blood pressure‡ 142  20 134  21 1.42 1.10, 1.82 .007
Diastolic blood pressure‡ 73  11 72  10 1.11 0.85, 1.45 .444
Clinical hypertension 30 (53%) 306 (39%) 1.71 0.99, 2.93 .052
Diabetes 10 (18%) 161 (21%) 0.81 0.40, 1.65 .567
Smoking 28 (49%) 355 (46%) 1.13 0.66, 1.94 .647
Hypercholesterolemia 8 (14%) 152 (18%) 0.67 0.31, 1.45 .313
Elevated LDL-C 11 (20%) 125 (17%) 1.23 0.62, 2.45 .551
Decreased HDL-C 16 (29%) 119 (16%) 2.17 1.18, 4.00 .013
Obesity 21 (37%) 224 (29%) 1.44 0.82, 2.52 .202
*See Table I for variable definitions.
†Odds ratio per 5-year increase.
‡Odds ratio per standard deviation increase.
LDL-C, Low-density lipoprotein cholesterol.
Table V. Results of multivariate analysis after forward,
stepwise variable selection (n  795)
Variable* Odds ratio 95% CI P value
Age† 1.34 1.03, 1.73 .0279
Decreased HDL-C 2.63 1.40, 4.93 .0026
Systolic blood pressure‡ 1.44 1.10, 1.87 .0074
*See Table I for variable definitions.
†Odds ratio per 5-year increase.
‡Odds ratio per standard deviation increase.
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et al22 examined the association between atherosclerotic
risk factors and a variety of subclinical diseases.22 These
authors defined the presence of subclinical disease with a
combined index that included abnormalities in electrocar-
diography, echocardiography, ankle-brachial blood pres-
sure, increased intimal carotid artery thickness, and a posi-
tive response on the Rose questionnaire for either angina or
claudication. With consideration of all 5201 adults in the
CHS, increased age, systolic blood pressure, blood glucose,
and cigarette use showed significant and independent asso-
ciations with the combined index of prevalent subclinical
disease at baseline. HDL-C was lower for both men and
women with subclinical disease; however, decreased
HDL-C showed a significant and independent association
with subclinical disease among women only. The findings
in this study support the notion that decreased HDL-C and
increased systolic blood pressure may be associated with
subclinical atherosclerosis at other sites. Although the hy-
pothesis implicating these covariates as initiators or pro-
moters of atherosclerotic RVD and other subclinical ath-
erosclerosis in the elderly cannot be explored in this report,
the question is worthy of further study.
In contrast to the observations in this report, the prev-
alence of RVD in black populations has long been consid-
ered low compared with white populations.23In large part,
this assumption was derived from the reported prevalence
of renovascular hypertension in black populations.24 On
the basis of these early data, most authorities recommended
that black patients with hypertension should not be
screened for RVD.25 Although the study of this CHS
cohort provides strong evidence that the presence of RVD
is not determined by ethnicity, this does not mean that
RVD contributes equally to hypertension in black and
white populations. We recently reported on our center’s
RDS study of 629 consecutive adults evaluated for severe
hypertension.26 Twelve percent of black subjects and 28%
of white subjects had RVD with RDS (P  .001). How-
ever, this highly significant difference should be viewed in
context of selection criteria for duplex study and racial
differences in essential hypertension. Because essential hy-
pertension in black subjects is more prevalent and more
severe within every age strata compared with white sub-
jects, proportionately fewer black subjects would be ex-
pected to have RVD when selected for RDS by the presence
of severe hypertension.26 With consideration of these ef-
fects in the context of this report, the clinical evaluation for
RVD should not be determined by race alone.
Otherwise, the overall prevalence of RVD described in
this study was much lower than estimates made from case
series of autopsy examinations or angiographic studies ob-
tained to evaluate other disease of the aorta or peripheral
circulation. In an unselected autopsy series, Schwartz and
White10 found RVD in 26% of patients of more than 75
years of age at death. In another large consecutive autopsy
series, Holley and coworkers11 found RVD in 62% of
individuals with hypertension 70 years of age and older.
These autopsy findings are supported with case series an-
giographic studies. Both Choudhri et al12 and Wilms and
colleagues13 reviewed consecutive angiograms performed
to evaluate for lower limb ischemia. Mean age in each study
was 67 and 63 years, respectively. Considered collectively,
RVD was present in 42% of subjects and involved both
kidneys in more than half of those subjects with disease.
Recently, reports by both Wachtell et al14 and Metcalfe,
Reid, and Geddes15 have noted 34% and 36% prevalence,
respectively, of RVD among a total of 527 patients evalu-
ated for peripheral vascular disease contributing to claudi-
cation, ischemic rest pain, or gangrene. Moreover, Valen-
tine et al16 noted similar findings in review of consecutive
angiograms performed to evaluate aortoiliac disease.
Among 346 patients with a mean age of 62 years, 28% had
unsuspected RVD.
Interestingly, the prevalence of RVD defined simulta-
neously with angiographic assessment of coronary artery
disease may be less than RVD associated with either infrain-
guinal or aortoiliac vascular disease. Conlon and cowork-
ers27 identified RVD among patients chosen for cardiac
catheterization studied simultaneously with abdominal
aortography. These authors reported that 15% of 1235
patients had RVD (ie,50% diameter-reducing renal artery
stenosis). Both Song et al28 and Gross et al29 performed
abdominal aortography in 427 and 609 patients, respec-
tively, chosen for diagnostic cardiac catheterization. These
authors observed RVD in 5.6% and 8.4% of patients, re-
spectively. Considering all three studies collectively, 50%
diameter-reducing renal artery stenosis was observed in
10% of patients chosen for routine cardiac catheterization.
When these results are considered in context of this study,
routine aortography performed in combination with diag-
nostic coronary angiography would seem of limited value:
the proportion of patients identified with RVD during
cardiac catheterization is similar to the prevalence of RVD
in our study cohort.
This ancillary project to the CHS showed a number of
unique strengths; however, a number of study limitations
deserve comment. Although the index subjects for the
CHS were selected through a two-step random process,
eligible members from the sampled individual’s household
also were recruited.18 This strategy was adopted to enhance
recruitment and retention of the defined elderly population
for longitudinal observation. As a result, the final CHS
cohort consisted of 70% of those initially sampled and 30%
were recruited because they shared the same household.
This recruitment strategy may have introduced an impor-
tant source of bias: significant differences existed between
randomly selected participants and those who chose not to
participate in the CHS. The refusal rate was higher among
women than men.18 The enrolled participants were
younger, more highly educated, more likely to be married,
and less likely to be smokers. In addition to this “healthy
cohort” effect, the recruitment for RDS may have intro-
duced other sources of bias. Compared with the 870 CHS
participants recruited for duplex study, CHS participants
declining study showed significant differences. The 375
participants who declined RDS were older and had a
greater history of tobacco use. Moreover, compared with
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the group with technically complete duplex studies, partic-
ipants with technically incomplete studies were older and
more obese and had more hypertension. Although the
number of incomplete duplex examinations was small and
was unlikely to introduce significant error, potential biases
inherent to cohort selection and participant recruitment
may have led to underestimation of RVD in the study
cohort.
Conversely, the screening method used in this study
may have overestimated atherosclerotic RVD. RDS dem-
onstrates many characteristics of an ideal screening method
for population-based estimates of RVD.19 The examina-
tion is noninvasive, poses no risk, and requires only an
overnight fast for preparation. During two previous pro-
spective comparison studies with angiography, RDS per-
formed at our center had a 93% to 94% sensitivity and an
88% to 98% specificity, with a 98% positive predictive value
for main renal artery stenosis and occlusion.19,20 However,
these prospective validating studies were conducted in pa-
tient populations with 44% and 70% prevalence of RVD.
Given the observed prevalence of 6.8% in this study cohort,
the positive predictive value for RDS in this study may be as
low as 37%, constituting an important potential source for
overestimation of RVD among studied participants.
Despite these potential study limitations, the Forsyth
County CHS cohort reflected a large, diverse group of
community-dwelling elderly black and white men and
women.17,18 As the number of elderly Americans increases
in both absolute and proportional terms, the healthcare
costs for their management will increase. The results from
RDS, in combination with data collected or being collected
as part of the CHS, will provide for important future
analysis.30 The association of RVD with established (ie,
clinical hypertension) and suggested (ie, renal insufficiency)
risk factors will be defined. Moreover, the contribution of
RVD to adverse cardiovascular events and its relationship
with other subclinical atherosclerotic disease will be examined.
In summary, RVD was present in 6.8% of free-living,
community-dwelling elderly men and women. RVD
showed no association with ethnicity but did show signifi-
cant and independent associations with increasing age, low
HDL-C levels, and increasing systolic blood pressure. Al-
though the scope of this report is limited, future analysis
will explore the association of RVD with excretory renal
function and the contribution of RVD to the risk of inci-
dent cardiovascular events on follow-up. These future find-
ings may provide rationale for the management of athero-
sclerotic RVD in the elderly.
We thank Mr. Scott Reavis, RVT, and Ms Jill Leighton
for their technical expertise and effort in performing the
renal duplex sonography.
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DISCUSSION
Dr R. James Valentine (Dallas, Tex). President Rosenthal,
members, and guests. Ten years ago, we reported a 27% prevalence
of renal artery stenoses in patients who underwent angiography for
lower extremity occlusive disease. None of these renal artery le-
sions was suspected on clinical grounds, but there was a higher
incidence of controlled hypertension and mild chronic renal insuf-
ficiency in the patients who did have stenoses.
In the excellent study that you have just heard, we have
learned that the prevalence of renal artery disease is much lower in
older subjects who were selected at random from the general
population. The low incidence of renal artery disease in patients
who do not have symptomatic atherosclerosis in other locations
should come as no surprise. The important message of this study is
that renal artery stenoses correlate with increasing age and low
HDL level, not with hypertension or with kidney size, except in the
rare patient with a renal artery occlusion.
The authors have performed an exceptionally good analysis,
and there are two particular strengths of this study that are worth
comment. First, it is an excellent study design. Patients were
recruited from a study population that was selected at random and
matched with a population distribution in Forsyth County, NC.
Second, the renal artery studies were technically superior. They
were all performed by two RVTs, and multiple Doppler samples
were imaged in each renal artery. Despite the rigorous definition of
technical success, 96% of the tests were technically satisfactory, and
the average time for all tests was an amazingly short 18 minutes.
My only criticism of this study is that there are no data on renal
function. The low prevalence of renal artery disease and the fact
that it did not correlate with hypertension suggests that there are
no subgroups in this population who should be considered for
routine screening. In the majority of patients, renal size was not
affected by the presence of a renal artery stenosis. However, before
we abandon screening altogether in this population, it would be
important to ensure that there is not some small subgroup of
patients (with renal insufficiency, for example) who might benefit
from renal artery revascularization. I am sure that the Winston-
Salem group will have the answer in no time.
I have two questions for the authors. First, when do you
intend to use renal duplex scans in older patients? The low inci-
dence of renal artery stenoses in this population is a clear argument
against using routine screening. Although we do not have renal
function data, one gets the distinct impression that the natural
history of these lesions is benign, so we might argue that renal scans
are never necessary in this population.
My related question is in regards to hypertension. The fact
that there was no significant correlation with hypertension sug-
gests that we would be hard pressed to use this as a criterion for
renal sonography. Was there any correlation between uncontrolled
hypertension and renal artery disease?
I congratulate Dr Edwards on an excellent presentation and
thank the authors for sending me a manuscript well in advance of
the meeting. I also wish to thank the program committee for the
invitation to comment on this paper.
Dr Matthew S. Edwards. Thank you, Dr Valentine, for
those insightful comments and questions. I would like to address
the hypertension and renal function issues first and then return to
the issue of screening.
Our goal with this project was to estimate the prevalence of
anatomic renovascular disease among community-dwelling elderly
Americans and to examine its associations with prior exposure to
traditional atherosclerotic risk factors. We chose to address the risk
factor question in this fashion in an attempt to separate the “risk
factor for lesion development” and “consequence of the lesion”
issues as much as possible. This was especially true with the issue of
hypertension, which is a known atherosclerotic risk factor as well as
a known potential consequence of anatomic renovascular disease.
Renal insufficiency, on the other hand, while it is a known potential
consequence of renovascular disease, is not a widely accepted risk
factor for the development of atherosclerosis. With those points in
mind, we included blood pressure but not renal insufficiency in the
risk factor analysis and we used blood pressure measurements taken
at the time of the enrollment baseline CHS examination, which
preceded the duplex exam by a minimum of 2 years in all cases.
When the risk factor question was analyzed in this fashion, it is true
that there was no association between a prior diagnosis of clinical
hypertension and a subsequent diagnosis of anatomic renovascular
disease. However, in an analysis that I did not present here today,
there was a strong and independent association between anatomic
renovascular disease and increasing levels of systolic hypertension
when measured at the time of duplex examination. These findings
suggest to us that hypertension may not be associated with reno-
vascular disease as much in a prior exposure or risk factor sense as it
is in a consequence sense. Furthermore, in another unpresented
analysis, elevated blood pressure was critical in defining a relation-
ship between anatomic renovascular disease and renal insufficiency.
To be more specific, there was a dependence or interaction be-
tween elevated levels of blood pressure and the presence of renal
artery stenosis or renal artery occlusion in predicting increasing
levels of serum creatinine. In other words, no relationship existed
between renovascular disease and increasing creatinine levels in the
absence of elevated blood pressure. Taken together, these points
suggest to us that hypertension remains an important indicator of
increased risk for the presence of anatomic renal artery disease and
for the potential for ischemia-related deteriorations in excretory
renal function.
This brings me to the screening issue. We screen for athero-
sclerotic renovascular disease in the elderly based primarily upon
the criterion of severe hypertension, as we feel that it identifies
individuals at higher risk for having an anatomic lesion and indi-
viduals at higher risk for a functionally significant anatomic lesion if
one is present. We feel that these results presented both in the
discussion and in the presentation support such a screening strat-
egy.
Dr Gary Gross (Hunstville, Ala). In our own vascular labs,
we have noticed at least a 10% false-positive rate per patient (5% per
artery) due to angulation of the renal artery, or incorrect beam
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angle. In your lab, what is the proven selectivity in renovascular
disease for duplex scanning? Could it be that the incidence of
renovascular disease in these patients is simply equal to the known
rate of false-positive studies? Secondly, have you looked at the renal
artery to aortic systolic velocity ratio? In some of these patients with
apparent disease by duplex, an elevated absolute renal artery veloc-
ity does not correlate with arteriographic findings when the aortic
velocity is proportionately increased as well.
Dr Edwards. Thank you for that question, Dr Gross. In our
experience with a large number of renovascular duplex exams, we
see an extremely low false-positive rate when compared with
contrast arteriography. I am not certain of the absolute number,
but it is less than 5%. In a recently published investigation by our
group looking at the same criteria that we used for this study, we
found a 94% sensitivity, 88% specificity, and 92% overall diagnostic
accuracy for the diagnosis of anatomic renovascular disease com-
pared with contrast arteriography.
In answer to the renal aortic ratio question, we do not employ
the renal aortic ratio as a criterion for diagnosis at our institution.
In previous investigations, we found a high degree of variability in
the aortic peak systolic velocities and demonstrated that peak
systolic velocity measures alone are at least equivalent in diagnostic
accuracy to the renal aortic ratio in diagnosing greater than 60%
stenoses. As a result, we now employ velocity measurements as a
single diagnostic criterion.
Dr Francis Robicsek (Charlotte, NC). Just a few quick
questions. What was the criterion to select the patient to the
general Cardiovascular Health Study? To me, it is somewhat
puzzling that when the patient agrees to participate in a study, later
one third of them refused simple Doppler examination. What is
your explanation for that?
Dr Edwards. The criteria for selection or for being initially
approached to participate in the Cardiovascular Health Study was
Medicare eligibility. The initial sample of patients to be contacted
was a random sample of such individuals in the four US commu-
nities that served as field centers for the CHS. Overall, the people
who participated were different than those contacted as one would
expect, and this issue has been examined by other investigators. Dr
Greta Tell has previously demonstrated that individuals who
agreed to participate in the CHS differed from those who declined
to participate in that participants tended to be younger, have a
higher perception of their own health, be more likely to be mar-
ried, less likely to be hypertensive, and more likely to have quit
smoking. As such, there may have been some degree of “healthy
cohort effect” or selection bias. When these individuals were
initially enrolled in the late 1980s and early 1990s, they were over
the age of 65 and they had selected percentages in each age
grouping that they tried to achieve. At the time of our ancillary
study, the population was even more advanced in age, and you are
exactly right, approximately a third of them declined duplex exam.
We had hoped for better recruitment efficiency, but 70% partici-
pation was not unexpected given the advanced age of these indi-
viduals. Those patients who declined duplex exam tended to be
older and more likely to use tobacco, both of which are known
predictors of nonparticipation in population-based studies.
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